The Coronavirus Outbreak Is Spreading...

Wuhan, China is the epicenter of an outbreak of the deadly coronavirus which has taken 82 lives. The disease continues to spread throughout the world, and it’s not just affecting our lives; it’s affecting stock markets. How far will the virus spread? Wuhan, China is the epicenter of an outbreak of the deadly coronavirus which has taken 82 lives. The disease continues to spread throughout the world, and it’s not just affecting our lives; it’s affecting stock markets. How far will the virus spread? [Wealth Daily logo] The Coronavirus Outbreak Is Spreading... [Monica Savaglia Photo] By [Monica Savaglia]( Written Jan. 28, 2020 Concerns continue to mount as the number of coronavirus cases increases daily and the area of infection widens. As of Monday morning, 82 people have died and more than 2,700 cases have been confirmed in mainland China. The disease is spreading throughout Asia. Here in the United States, there are at least five cases that have been confirmed. On Monday, the U.S. Centers for Disease Control and Prevention (CDC) said that there have been no new confirmed cases of the coronavirus in the U.S. since the last update on Sunday. Nancy Messonnier, the director of the CDC’s National Center for Immunization and Respiratory Diseases, notified the public that the CDC is investigating 110 possible cases in 26 states. Messonnier had this to say during a conference call on Monday: We understand that many people in the United States are worried about this virus and how it will affect Americans. Every day we learn more, every day we assess to see if our guidelines or our response can be improved. The coronavirus is being compared to the 2003 outbreak of SARS, which had a short incubation period of two to seven days. The large family of coronaviruses usually infects animals but can spread to humans. Symptoms in humans include fever, coughing, and shortness of breath which can eventually progress to pneumonia. As of right now, the World Health Organization (WHO) hasn’t declared a global health emergency, but the situation is being monitored heavily. Not keeping an eye on the outbreak of this virus would be detrimental to the world. WHO’s director-general is set to meet with government and health officials in China to analyze data to determine if the virus is a worldwide emergency. Elon Musk Can’t Survive Without This “Miracle Metal”… ... And the coming supply-demand squeeze is about to break out in an all-out war. Tech giants (like Tesla and Apple), China, and even President Trump are already fighting over it. Find out [here]( what it is and how YOU can profit. China has restricted travel to prevent the spread of the virus. City officials in Wuhan, China, the epicenter of the outbreak, have put its population of about 11 million people on lockdown to contain the disease and prevent further transmission in the region. Researchers have discovered that it may be possible for people who are infected to spread the virus before they have any visible symptoms. U.S. officials say symptoms from the new virus, which they have temporarily named 2019-nCoV, can take up to 14 days to appear. The CDC is working hard at speeding up testing and getting those tests in the hands of state health officials. Currently, it’s taking the CDC four to six hours to make a diagnosis when a sample makes it to its lab. It is flu season, which means the flu and other respiratory illnesses could result in officials not accurately identifying more cases. A lot could go wrong if the necessary precautions aren’t taken in this delicate matter, with implications that could be felt throughout the world. Stock markets are being affected by the spread of the coronavirus. On Monday, the Dow futures fell around 1.6%. There was also a 1.6% drop in the S&P 500 futures. And Nasdaq futures lowered by about 2.1%. Concerns are lingering in the market. Travel stocks like American Airlines Group (NASDAQ: AAL) fell more than 8% Monday morning, and Delta Air Lines (NYSE: DAL) experienced a drop in its shares as well. Analysts at Dutch bank Rabobank said, “As the human cost continues to rise, investors have become increasingly concerned about the potential economic consequences of the disease.” Carnival (NYSE: CCL) and Royal Caribbean (NYSE: RCL) experienced about a 5% drop when the market opened up on Monday morning. Investors are holding off on travel stocks until there is a better understanding of exactly how dangerous this virus will get. China accounts for about 5% of the global cruise capacity and is the high-end go-to destination location for cruise lines like Carnival and Royal Caribbean. If cruise lines are canceling trips and port calls in countries affected by the spread of the virus, that’ll reflect in the companies’ first-quarter earnings. That could mean bad news for long-term growth. Looming legislation set to spark cannabis fortunes A historic piece of cannabis legislation is moving through the halls of Congress. And it has widespread support from BOTH sides of the aisle. This bill could be on Trump’s desk by the end of the year... if not much sooner. [Click here]( for the shocking details. However, there are some stocks that have been seeing movement with the news of the coronavirus. Biotech stocks, even the ones that haven’t been directly related to the outbreak, have experienced an uptick. Either way, the sector has been rising and some companies have publicly announced they are working on a vaccine and assisting with quicker detection. Let’s take a look at one unlikely biotech, Vir Biotechnology, a clinical-stage immunology company that surged 38% because of the coronavirus. This rally began on Thursday last week when the company made the announcement that it’ll be “working to rapidly determine whether its previously identified anti-coronavirus monoclonal antibodies (mAbs) bind and neutralize 2019-nCoV." Vir’s CEO, George Scangos, Ph.D. said, “We don’t know yet if these efforts will be successful, but we are working aggressively to find out.” This is just one example of how biotech companies are doing what they can to help control the virus. The biotech sector tends to experience massive gains that many people are unaware of. It’s a breakthrough industry with amazing potential. The sector often intimidates investors because it requires a lot of attention, but that doesn’t have to be the case, especially at a time when biotechs are working fast to develop a vaccine and dedicating their resources to containing the spread of the coronavirus. [Watch this presentation]( on the biotech sector. It’ll give you insight into how to be on the lookout for events that could [easily help build your wealth](. Until next time, [Monica Savaglia Signature Park Avenue Digest] Monica Savaglia Monica Savaglia is Wealth Daily’s IPO specialist. With passion and knowledge, she wants to open up the world of IPOs and their long-term potential to everyday investors. She does this through her newsletter [IPO Authority](, a one-stop resource for everything IPO. She also contributes regularly to the [Wealth Daily]( e-letter. To learn more about Monica, [click here](. How to Become a Millionaire Before the Next Election It’s no secret that socialism is on the rise in America. And it’s getting more and more dangerous every single day. I don’t mean to be a fear monger, but look at the facts. I mean, we’re just a couple of months away from Trump’s reelection, and there’s an actual impeachment trial going on in the Senate as we speak. These are dangerous, rogue politicians, and they all have one goal: Tax the ever-living daylight out of hardworking Americans like you and me. Dear reader, we’re running out of time. I can help you find and invest in enormous opportunities, with the potential to provide real, generational wealth. There’s no doubt this is the single fastest way I know to build extreme wealth in America. [Find out how you can get started today](. Enjoy reading this article? [Click here]( to like it and receive similar articles to read! Browse Our Archives [The Sum of All Fears]( [The World's Elite Are Betting on 5G Infrastructure at Davos]( [SpaceX Is Having a Good Week]( [EV Stocks Love the China Deal]( [Great Product, Bad Company, Terrible Stock]( --------------------------------------------------------------- This email was sent to {EMAIL}. It is not our intention to send email to anyone who doesn't want it. If you're not sure why you've received this e-letter, or no longer wish to receive it, you may [unsubscribe here](, and view our privacy policy and information on how to manage your subscription. To ensure that you receive future issues of Wealth Daily, please add newsletter@wealthdaily.com to your address book or whitelist within your spam settings. For customer service questions or issues, please contact us for assistance. [Wealth Daily](, Copyright © 2020, [Angel Publishing LLC](. All rights reserved. 111 Market Place #720 Baltimore, MD 21202. The content of this site may not be redistributed without the express written consent of Angel Publishing. Individual editorials, articles and essays appearing on this site may be republished, but only with full attribution of both the author and Wealth Daily as well as a link to www.wealthdaily.com. Your privacy is important to us -- we will never rent or sell your e-mail or personal information. [View our privacy policy here.]( No statement or expression of opinion, or any other matter herein, directly or indirectly, is an offer or the solicitation of an offer to buy or sell the securities or financial instruments mentioned. While we believe the sources of information to be reliable, we in no way represent or guarantee the accuracy of the statements made herein. [Wealth Daily]( does not provide individual investment counseling, act as an investment advisor, or individually advocate the purchase or sale of any security or investment. Neither the publisher nor the editors are registered investment advisors. Subscribers should not view this publication as offering personalized legal or investment counseling. Investments recommended in this publication should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company in question.